0001127602-23-001492.txt : 20230117
0001127602-23-001492.hdr.sgml : 20230117
20230117192812
ACCESSION NUMBER: 0001127602-23-001492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230112
FILED AS OF DATE: 20230117
DATE AS OF CHANGE: 20230117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeLong Mark Jeffrey
CENTRAL INDEX KEY: 0001856078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 23532593
MAIL ADDRESS:
STREET 1: 100 5TH AVENUE, 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-01-12
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001856078
DeLong Mark Jeffrey
C/O APELLIS PHARMACEUTICALS, INC.
WALTHAM
MA
02451
1
Chief Business & Strat Officer
Common Stock
2023-01-12
4
A
0
19634
0
A
48688
D
Stock Option (Right to Buy)
52.66
2023-01-12
4
A
0
30845
52.66
A
2033-01-11
Common Stock
30845
30845
D
This represents a Restricted Stock Unit award granted 01/12/23 that vest annually from grant date over a four year period subject to continued service.
This represents a stock option award granted 01/12/2023 that vest over a four year period. 25% vest one year from grant date and the remaining 75% vest monthly thereafter subject to continued service.
/s/ David Watson, attorney-in-fact for Mark DeLong
2023-01-17